Lazerhead Pharma Limited, a active public limited company, was established on 19 January 1979 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1979PLC072986. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.25 M.
Formerly known as Macmohan Pharma Limited. It upholds a compliant status. Employing 4 professional, Its leadership includes Anil Mohan Rao Yelamanchi (Managing Director), Yelamanchi Padma Rao (Director), Ramamohan Rao Yelamanchi (Director). Past directors included Anil Mohan Rao Yelamanchi, Marceline Rao, Ramamohan Rao Yelamanchi. It holds ₹3.39 M open charges and ₹1.30 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302, Bhavya'S Fantastika Road No: 12, Banjara Hills, Hyderabad, Telangana, 500034.
U24230TG1979PLC072986
072986
19 January 1979
₹2.50 M
₹2.25 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Lazerhead Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Mohan Rao Yelamanchi | Managing Director | 01 Jul 1996 | Current |
| Yelamanchi Padma Rao | Director | 30 Sep 2015 | Current |
| Ramamohan Rao Yelamanchi | Director | 14 Aug 1979 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2010 | Past |
| Pramod Abcsdd | Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Managing Director | 01 Jan 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lazerhead Pharma Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 4.6% increase. The company also saw a substantial improvement in profitability, with a 65.38% increase in profit. The company's net worth Soared by an impressive increase of 33.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Lazerhead Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,387,000.00
₹13,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 1992 | A P State Financial Corporation | ₹2.51 M | Open |
| 09 Jan 1981 | State Bank Of India | ₹0.48 M | Open |
| 21 Dec 1979 | A P State Financial Corporation | ₹0.40 M | Open |
| 24 Feb 2011 | Axis Bank Limited | ₹3.00 M | Satisfied |
| 31 Mar 2008 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Lazerhead Pharma has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lazerhead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lazerhead Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lazerhead Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Lazerhead Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Yelamanchi Padma Rao was appointed as a Director was appointed as a Director on 30 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
Progress on A charge registered on 24 Feb 2011 via Charge ID 10269098 with Axis Bank Limited was fully satisfied on 19 Nov 2013. was documented.
Progress on A charge registered on 31 Mar 2008 via Charge ID 10096928 with Axis Bank Limited was fully satisfied on 19 Nov 2013. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 3.00 M with Charge ID 10269098 was registered on 24 Feb 2011. was completed.
The CIN of Lazerhead Pharma Limited is U24230TG1979PLC072986.
Lazerhead Pharma Limited is headquartered at 302, Bhavya'S Fantastika Road No: 12, Banjara Hills, Hyderabad, Telangana, 500034.
Lazerhead Pharma Limited was incorporated on 19 January 1979.
The current directors of Lazerhead Pharma Limited are
The primary industry of Lazerhead Pharma Limited is Manufacturing.
Lazerhead Pharma Limited is unlisted.
The authorized capital of Lazerhead Pharma Limited is ₹2.50 M, and the paid-up capital is ₹2.25 M.
The compliance status of Lazerhead Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX